BDBM123083 US10213421, Example 9::US11612596, Example 9.::US8742115, 23

SMILES Cc1cc(cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1)C(=O)NC1CCC1

InChI Key InChIKey=VLDHAXJQQANHCX-RUZDIDTESA-N

Data  3 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 123083   

TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123083(US10213421, Example 9 | US11612596, Example 9. | U...)
Affinity DataKi:  4.20nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123083(US10213421, Example 9 | US11612596, Example 9. | U...)
Affinity DataKi:  4.20nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125lodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123083(US10213421, Example 9 | US11612596, Example 9. | U...)
Affinity DataKi:  4.20nMAssay Description:Assay is described in WO 2010 115836.More data for this Ligand-Target Pair
In DepthDetails US Patent